Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells.

Ho JC, Lai WH, Li MF, Au KW, Yip MC, Wong NL, Ng ES, Lam FF, Siu CW, Tse HF.

Diabetes Metab Res Rev. 2012 Jul;28(5):462-73. doi: 10.1002/dmrr.2304. Epub 2012 Apr 10.

PMID:
22492468
2.

Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus.

De Falco E, Avitabile D, Totta P, Straino S, Spallotta F, Cencioni C, Torella AR, Rizzi R, Porcelli D, Zacheo A, Di Vito L, Pompilio G, Napolitano M, Melillo G, Capogrossi MC, Pesce M.

J Cell Mol Med. 2009 Sep;13(9B):3405-14. doi: 10.1111/j.1582-4934.2009.00655.x.

3.

Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.

Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):551-9. doi: 10.1161/ATVBAHA.110.220624. Epub 2010 Dec 9.

4.

Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells.

Lai WH, Ho JC, Chan YC, Ng JH, Au KW, Wong LY, Siu CW, Tse HF.

PLoS One. 2013;8(3):e57876. doi: 10.1371/journal.pone.0057876. Epub 2013 Mar 5.

5.

Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.

Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS.

Circulation. 2005 Sep 13;112(11):1618-27. Epub 2005 Sep 6.

6.

Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, Kaufman DS.

Exp Hematol. 2010 Mar;38(3):246-257.e1. doi: 10.1016/j.exphem.2010.01.001. Epub 2010 Jan 11.

8.

Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.

Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM.

Circulation. 2007 Nov 20;116(21):2409-19. Epub 2007 Nov 5.

9.

Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.

Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):984-91. doi: 10.1161/ATVBAHA.110.202796. Epub 2010 Feb 18.

10.

Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.

Raida M, Heymann AC, Günther C, Niederwieser D.

Int J Mol Med. 2006 Oct;18(4):735-9.

PMID:
16964430
11.

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A.

Cardiovasc Diabetol. 2014 Nov 1;13:150. doi: 10.1186/s12933-014-0150-7. Erratum in: Cardiovasc Diabetol. 2015;14:65.

12.

Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.

Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM, Lee MJ, Jang IH, Kwon SM, Lee JS, Kim JH.

Biochim Biophys Acta. 2013 Dec;1832(12):2136-44. doi: 10.1016/j.bbadis.2013.08.002. Epub 2013 Aug 16.

13.

Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.

Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C.

PLoS One. 2009 May 21;4(5):e5643. doi: 10.1371/journal.pone.0005643.

14.

Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.

Sanchez-Guijo FM, Oterino E, Barbado MV, Carrancio S, Lopez-Holgado N, Muntion S, Hernandez-Campo P, Sanchez-Abarca LI, Perez-Simon JA, San Miguel JF, Briñon JG, del Cañizo MC.

Cell Transplant. 2010;19(1):103-12. doi: 10.3727/096368909X476869. Epub 2009 Oct 9.

PMID:
19818207
15.

Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia.

Oda M, Toba K, Ozawa T, Kato K, Yanagawa T, Ikarashi N, Takayama T, Suzuki T, Hanawa H, Fuse I, Nakata K, Narita M, Takahashi M, Aizawa Y.

J Mol Cell Cardiol. 2010 Sep;49(3):347-53. doi: 10.1016/j.yjmcc.2010.04.001. Epub 2010 Apr 9.

PMID:
20382155
16.

Smooth muscle progenitor cells from peripheral blood promote the neovascularization of endothelial colony-forming cells.

Joo HJ, Seo HR, Jeong HE, Choi SC, Park JH, Yu CW, Hong SJ, Chung S, Lim DS.

Biochem Biophys Res Commun. 2014 Jul 11;449(4):405-11. doi: 10.1016/j.bbrc.2014.05.061. Epub 2014 May 22.

PMID:
24858689
17.

Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells.

Boon RA, Urbich C, Fischer A, Fontijn RD, Seeger FH, Koyanagi M, Horrevoets AJ, Dimmeler S.

Eur Heart J. 2011 Feb;32(3):371-7. doi: 10.1093/eurheartj/ehq137. Epub 2010 May 21.

PMID:
20494899
18.

CD34⁺/M-cadherin⁺ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE⁻/⁻ mice.

Terry T, Chen Z, Dixon RA, Vanderslice P, Zoldhelyi P, Willerson JT, Liu Q.

PLoS One. 2011;6(6):e20673. doi: 10.1371/journal.pone.0020673. Epub 2011 Jun 3.

19.

Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.

Tepeköylü C, Wang FS, Kozaryn R, Albrecht-Schgoer K, Theurl M, Schaden W, Ke HJ, Yang Y, Kirchmair R, Grimm M, Wang CJ, Holfeld J.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):971-8. doi: 10.1016/j.jtcvs.2013.01.017. Epub 2013 Feb 8.

20.

Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.

Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):709-17. doi: 10.1161/ATVBAHA.112.300318. Epub 2013 Feb 14.

Supplemental Content

Support Center